Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms

被引:0
作者
Cheng Fang
Wei Wang
Xingyu Feng
Jian Sun
Yu Zhang
Yujie Zeng
Junjiang Wang
Huishan Chen
Muyan Cai
Junzhong Lin
Minhu Chen
Ye Chen
Yong Li
Shengping Li
Jie Chen
Zhiwei Zhou
机构
[1] Sun Yat-sen University Cancer Center,Department of Gastric Surgery
[2] State Key Laboratory of Oncology in South China,Department of General Surgery
[3] Collaborative Innovation Center for Cancer Medicine,Department of Biliopancreatic Surgery
[4] Guangdong General Hospital,Department of Gastroenterology
[5] Guangdong Academy of Medical Science,Department of Gastrointestinal Surgery
[6] Sun Yat-sen Memorial Hospital of Sun Yat-sen University,Department of Gastroenterology
[7] Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Department of Pathology
[8] First Affiliated Hospital of Sun Yat-sen University,Department of Colorectal Surgery
[9] Sun Yat-sen Memorial Hospital of Sun Yat-sen University,Department of Hepatopancreatobiliary Surgery
[10] Nanfang Hospital of Southern Medical University,undefined
[11] Guangdong Provincial Key Laboratory of Gastroenterology,undefined
[12] Guangzhou,undefined
[13] People’s Republic of China,undefined
[14] Sun Yat-sen University Cancer Center,undefined
[15] Sun Yat-sen University Cancer Center,undefined
[16] Sun Yat-sen University Cancer Center,undefined
来源
British Journal of Cancer | 2017年 / 117卷
关键词
nomogram; gastroenteropancreatic neuroendocrine neoplasms; predict; overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1544 / 1550
页数:6
相关论文
共 50 条
  • [31] Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms
    Liao, Tianbao
    Su, Tingting
    Huang, Lina
    Li, Bixun
    Feng, Lu-Huai
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (01) : 85 - 90
  • [32] Development and validation of a nomogram for predicting the overall survival of patients with testicular cancer
    Yu, Haohui
    Feng, Bin
    Zhang, Yunrui
    Lyu, Jun
    CANCER MEDICINE, 2023, 12 (14): : 15567 - 15578
  • [33] A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma
    Yeh, Chun-Nan
    Wang, Shang-Yu
    Chen, Yen-Yang
    Chen, Ming-Huang
    Chiang, Kun-Chun
    Cheng, Chi-Tung
    Tsai, Chun-Yi
    Wang, Chih-Chi
    Yeh, Ta-Sen
    Chen, Tse-Ching
    ANTICANCER RESEARCH, 2016, 36 (08) : 4249 - 4258
  • [34] Development and Validation a Nomogram for Predicting Overall Survival in Patients With Intrahepatic Cholangiocarcinoma
    Yuan, Chen
    Hu, Zhigang
    Wang, Kai
    Zou, Shubing
    FRONTIERS IN SURGERY, 2021, 8
  • [35] New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
    Yin, Feng
    Wu, Zi-Hao
    Lai, Jin-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (17) : 1751 - 1767
  • [36] Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma
    Zhao, Jin-du
    Lu, Xian-ying
    Chen, Tian -ping
    Duan, Xian-Lun
    Zuo, Wei
    Sai, Kai
    Zhu, Li -ran
    Gao, Qun
    EJSO, 2024, 50 (06):
  • [37] Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms
    Attili, Fabia
    Capurso, Gabriele
    Vanella, Giuseppe
    Fuccio, Lorenzo
    Delle Fave, Gianfranco
    Costamagna, Guido
    Larghi, Alberto
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (01) : 9 - 17
  • [38] Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram
    Xu, Yan-Bo
    Liu, Hong
    Cao, Qi-Hua
    Ji, Jia-Li
    Dong, Rong-Rong
    Xu, Dong
    CANCER MEDICINE, 2020, 9 (12): : 4095 - 4106
  • [39] Machine learning predicts prognosis in patients with gastroenteropancreatic neuroendocrine tumors with liver metastases
    Fuli Gao
    Jian Chen
    Xiaodan Xu
    Discover Oncology, 16 (1)
  • [40] A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
    Wei, Xuan
    Hu, Wencheng
    Mao, Kexi
    MEDICINE, 2023, 102 (05) : E32766